Take off with Check-Cap Ltd. (CHEK): Get ready for trading

Check-Cap Ltd. (NASDAQ: CHEK) stock fell -1.40% on Wednesday to $4.64 against a previous-day closing price of $4.71. With 17253.0 shares changed hands, the volume of the stock remained lighter than its average volume of 26820.0 shares. During the session, the Diagnostics & Research company that operates in wider Healthcare sector, reached to the highest price of $0.2499 whereas the lowest price it dropped to was $0.2310. The 52-week range on CHEK shows that it touched its highest point at $0.89 and its lowest point at $0.23 during that stretch. It currently has a 1-year price target of $3.00. Beta for the stock currently stands at 0.40.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CHEK was down-trending over the past week, with a drop of -9.02%, but this was down by -6.07% over a month. Three-month performance dropped to -33.03% while six-month performance fell -25.19%. The stock lost -69.07% in the past year, while it has lost -65.61% so far this year. A look at the trailing 12-month EPS for CHEK yields -0.20 with Next year EPS estimates of -0.17. For the next quarter, that number is -0.04. This implies an EPS growth rate of 54.50% for this year and 11.10% for next year.

Float and Shares Shorts:

At present, 116.41 million CHEK shares are outstanding with a float of 112.69 million shares on hand for trading. On Oct 30, 2022, short shares totaled 1.0 million, which was 0.86% higher than short shares on Sep 29, 2022. In addition to Mr. Alex Ovadia as the firm’s CEO & Director, Dr. Yoav Kimchy Ph.D. serves as its Founder & Chief Technology Officer.

Institutional Ownership:

Through their ownership of 0.78% of CHEK’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 0.57% of CHEK, in contrast to 0.10% held by mutual funds. Shares owned by individuals account for –. As the largest shareholder in CHEK with 0.12% of the stake, G1 Execution Services LLC holds 140,382 shares worth 140,382. A second-largest stockholder of CHEK, Citadel Securities LLC, holds 141,319 shares, controlling over 0.12% of the firm’s shares. Virtu Financial BD LLC is the third largest shareholder in CHEK, holding 125,260 shares or 0.11% stake. With a 0.05% stake in CHEK, the Perritt Ultra Micro Cap Fund is the largest stakeholder. A total of 61,758 shares are owned by the mutual fund manager. The Fidelity Nasdaq Composite Index F, which owns about 0.05% of CHEK stock, is the second-largest Mutual Fund holder. It holds 58,636 shares valued at 14073.0.

An Overview of Recent Financials:

Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Jun 29, 2022, CHEK reported revenue of $0.00 and operating income of -$4.89M. Over the past year, revenue came in at $0.00 while operating income stood at -$20.61M. It generated -$4.81M net income for the quarter, which came to -$20.36M over the last twelve months. The EBITDA in the recently reported quarter was -$4.80M and diluted EPS was -$0.04. EBITDA for the full year was -$20.22M.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CHEK since 2 analysts follow the stock currently. There are 1 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With CHEK analysts setting a high price target of $3.00 and a low target of $3.00, the average target price over the next 12 months is $3.00. Based on these targets, CHEK could drop -35.34% to reach the target high and fall by -35.34% to reach the target low. Reaching the average price target will result in a decline of -35.34% from current levels.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. CHEK will report FY 2022 earnings on 03/10/2023. Analysts have provided yearly estimates in a range of -$0.15 being high and -$0.20 being low. For CHEK, this leads to a yearly average estimate of -$0.17. The earnings surprise of a firm occurs when the actual results change from the consensus earnings estimate. Check-Cap Ltd. surprised analysts by -$0.01 when it reported -$0.04 EPS against a consensus estimate of -$0.04. The surprise factor in the prior quarter was -$0.01. Based on analyst estimates, the high estimate for the next quarter is -$0.04 and the low estimate is -$0.05. The average estimate for the next quarter is thus -$0.04.

Leave a Comment

Your email address will not be published. Required fields are marked *




The 5 Best Inflation Stocks for 2022

100% free. stop anytime no spam

Get our free report on the stocks that we recommend for investors who want to protect their portfolios from inflation.

Receive Best Stock To Trade Before The Opening Bell



100% Free. Stop Anytime. No Spam